Forcyte Biotechnologies, Inc. — Form D/A
Forcyte Biotechnologies, Inc. of LOS ANGELES, CA, a company, filed a Form D amendment with the SEC on 2019-01-15. The offering totals $2.0M, of which $160K was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-01-15
- Form: D/A
- Accession: 0001760069-19-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $160K
- Remaining: $1.8M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2018-12-18
- Revenue range: No Revenues
- SEC file number: 021-330118
Issuer
- Name: Forcyte Biotechnologies, Inc.
- CIK: 0001760069
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 11957 DARLINGTON AVENUE, LOS ANGELES, CA, 90049
- Phone: 8594204398
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Ivan Pushkarsky | Executive Officer | Los Angeles, CA |
Other filings by this issuer (1)
More